This site uses cookies, including third-party cookies, that help us to provide and improve our services. Read More

Pharyngitis Market Insights

Pharyngitis Market Insights

Pharyngitis Market Forecast, Trend Analysis & Competition Tracking – Global Market insights 2017 to 2026

Pharyngitis Market Insights
FACT361MR
  • Dec-2017
  • List of Tables : 146
  • List of Figures : 90
  • 170 Pages
  • Healthcare

Table of Content

1. Global Economic Outlook

2. Global Pharyngitis Market - Executive Summary

3. Global Pharyngitis Market Overview

3.1. Introduction

       3.1.1. Global Pharyngitis Market Taxonomy

       3.1.2. Global Pharyngitis Market Definition

3.2. Global Pharyngitis Market Size (US$ Mn) and Forecast, 2012-2026

       3.2.1. Global Pharyngitis Market Y-o-Y Growth

3.3. Global Pharyngitis Market Dynamics

3.4. Supply Chain

3.5. Cost Structure

3.6. Pricing Analysis 

3.7. Drug Pipeline Assessment

3.8. Product Life Cycle

3.9. PEST Analysis

4. Global Pharyngitis Market Analysis and Forecast 2012-2026 

4.1. Global Pharyngitis Market Size and Forecast By Drug Class, 2012-2026

       4.1.1. Beta Lactams Market Size and Forecast, 2012-2026

                4.1.1.1. Revenue (US$ Mn) Comparison, By Region

                4.1.1.2. Market Share Comparison, By Region

                4.1.1.3. Y-o-Y growth Comparison, By Region

       4.1.2. Macrolides Market Size and Forecast, 2012-2026

                4.1.2.1. Revenue (US$ Mn) Comparison, By Region

                4.1.2.2. Market Share Comparison, By Region

                4.1.2.3. Y-o-Y growth Comparison, By Region

       4.1.3. Cephalosporins Market Size and Forecast, 2012-2026

                4.1.3.1. Revenue (US$ Mn) Comparison, By Region

                4.1.3.2. Market Share Comparison, By Region

                4.1.3.3. Y-o-Y growth Comparison, By Region

       4.1.4. Fluoroquinolones Market Size and Forecast, 2012-2026

                4.1.4.1. Revenue (US$ Mn) Comparison, By Region

                4.1.4.2. Market Share Comparison, By Region

                4.1.4.3. Y-o-Y growth Comparison, By Region

       4.1.5. Tetracycline Market Size and Forecast, 2012-2026

                4.1.5.1. Revenue (US$ Mn) Comparison, By Region

                4.1.5.2. Market Share Comparison, By Region

                4.1.5.3. Y-o-Y growth Comparison, By Region

       4.1.6. Other Products Market Size and Forecast, 2012-2026

                4.1.6.1. Revenue (US$ Mn) Comparison, By Region

                4.1.6.2. Market Share Comparison, By Region

                4.1.6.3. Y-o-Y growth Comparison, By Region

4.2. Global Pharyngitis Market Size and Forecast By Distribution Channel, 2012-2026

       4.2.1. Hospital Pharmacies Market Size and Forecast, 2012-2026

                4.2.1.1. Revenue (US$ Mn) Comparison, By Region

                4.2.1.2. Market Share Comparison, By Region

                4.2.1.3. Y-o-Y growth Comparison, By Region

       4.2.2. Retail Pharmacies and Drug Stores Market Size and Forecast, 2012-2026

                4.2.2.1. Revenue (US$ Mn) Comparison, By Region

                4.2.2.2. Market Share Comparison, By Region

                4.2.2.3. Y-o-Y growth Comparison, By Region

       4.2.3. Online Pharmacies Market Size and Forecast, 2012-2026

                4.2.3.1. Revenue (US$ Mn) Comparison, By Region

                4.2.3.2. Market Share Comparison, By Region

                4.2.3.3. Y-o-Y growth Comparison, By Region

4.3. Global Pharyngitis Market Size and Forecast By Mode of Delivery, 2012-2026

       4.3.1. Oral Market Size and Forecast, 2012-2026

                4.3.1.1. Revenue (US$ Mn) Comparison, By Region

                4.3.1.2. Market Share Comparison, By Region

                4.3.1.3. Y-o-Y growth Comparison, By Region

       4.3.2. Intravenous Market Size and Forecast, 2012-2026

                4.3.2.1. Revenue (US$ Mn) Comparison, By Region

                4.3.2.2. Market Share Comparison, By Region

                4.3.2.3. Y-o-Y growth Comparison, By Region

       4.3.3. Intramuscular Market Size and Forecast, 2012-2026

                4.3.3.1. Revenue (US$ Mn) Comparison, By Region

                4.3.3.2. Market Share Comparison, By Region

                4.3.3.3. Y-o-Y growth Comparison, By Region

       4.3.4. Other Mode of Delivery Market Size and Forecast, 2012-2026

                4.3.4.1. Revenue (US$ Mn) Comparison, By Region

                4.3.4.2. Market Share Comparison, By Region

                4.3.4.3. Y-o-Y growth Comparison, By Region

5. North America Pharyngitis Market Size and Forecast, 2012-2026

5.1. North America Outlook 

5.2. North America Parent Market Outlook 

5.3. North America Target Market Outlook 

5.4. Revenue (US$ Mn) Comparison, By Country 

       5.4.1. US Market Size and Forecast (US$ Mn), 2012-2026

       5.4.2. Canada Market Size and Forecast (US$ Mn), 2012-2026

5.5. Revenue (US$ Mn) Comparison, By Drug Class 

5.6. Revenue (US$ Mn) Comparison, By Distribution Channel 

5.7. Revenue (US$ Mn) Comparison, By Mode of Delivery 

6. Latin America Pharyngitis Market Size and Forecast, 2012-2026

6.1. Latin America Outlook 

6.2. Latin America Parent Market Outlook 

6.3. Latin America Target Market Outlook 

6.4. Revenue (US$ Mn) Comparison, By Country 

       6.4.1. Brazil Market Size and Forecast (US$ Mn), 2012-2026

       6.4.2. Mexico Market Size and Forecast (US$ Mn), 2012-2026

       6.4.3. Rest of Latin America Market Size and Forecast (US$ Mn), 2012-2026

6.5. Revenue (US$ Mn) Comparison, By Drug Class 

6.6. Revenue (US$ Mn) Comparison, By Distribution Channel 

6.7. Revenue (US$ Mn) Comparison, By Mode of Delivery 

7. Europe Pharyngitis Market Size and Forecast, 2012-2026

7.1. Europe Outlook 

7.2. Europe Parent Market Outlook 

7.3. Europe Target Market Outlook 

7.4. Revenue (US$ Mn) Comparison, By Country 

       7.4.1. Germany Market Size and Forecast (US$ Mn), 2012-2026

       7.4.2. UK Market Size and Forecast (US$ Mn), 2012-2026

       7.4.3. France Market Size and Forecast (US$ Mn), 2012-2026

       7.4.4. Spain Market Size and Forecast (US$ Mn), 2012-2026

       7.4.5. Italy Market Size and Forecast (US$ Mn), 2012-2026

       7.4.6. Rest of Europe Market Size and Forecast (US$ Mn), 2012-2026

7.5. Revenue (US$ Mn) Comparison, By Drug Class 

7.6. Revenue (US$ Mn) Comparison, By Distribution Channel 

7.7. Revenue (US$ Mn) Comparison, By Mode of Delivery 

8. Japan Pharyngitis Market Size and Forecast, 2012-2026

8.1. Japan Outlook 

8.2. Japan Parent Market Outlook 

8.3. Japan Target Market Outlook 

8.4. Revenue (US$ Mn) Comparison, By Country 

       8.4.1. Japan  Market Size and Forecast (US$ Mn), 2012-2026

8.5. Revenue (US$ Mn) Comparison, By Drug Class 

8.6. Revenue (US$ Mn) Comparison, By Distribution Channel 

8.7. Revenue (US$ Mn) Comparison, By Mode of Delivery 

9. APEJ Pharyngitis Market Size and Forecast, 2012-2026

9.1. APEJ Outlook 

9.2. APEJ Parent Market Outlook 

9.3. APEJ Target Market Outlook 

9.4. Revenue (US$ Mn) Comparison, By Country 

       9.4.1. China Market Size and Forecast (US$ Mn), 2012-2026

       9.4.2. India Market Size and Forecast (US$ Mn), 2012-2026

       9.4.3. Australia Market Size and Forecast (US$ Mn), 2012-2026

       9.4.4. Thailand Market Size and Forecast (US$ Mn), 2012-2026

       9.4.5. Singapore Market Size and Forecast (US$ Mn), 2012-2026

       9.4.6. Rest of APEJ Market Size and Forecast (US$ Mn), 2012-2026

9.5. Revenue (US$ Mn) Comparison, By Drug Class 

9.6. Revenue (US$ Mn) Comparison, By Distribution Channel 

9.7. Revenue (US$ Mn) Comparison, By Mode of Delivery 

10. MEA Pharyngitis Market Size and Forecast, 2012-2026

10.1. MEA Outlook 

10.2. MEA Parent Market Outlook 

10.3. MEA Target Market Outlook 

10.4. Revenue (US$ Mn) Comparison, By Country 

       10.4.1. GCC Countries Market Size and Forecast (US$ Mn), 2012-2026

       10.4.2. South Africa Market Size and Forecast (US$ Mn), 2012-2026

       10.4.3. Nigeria Market Size and Forecast (US$ Mn), 2012-2026

       10.4.4. Rest of MEA Market Size and Forecast (US$ Mn), 2012-2026

10.5. Revenue (US$ Mn) Comparison, By Drug Class 

10.6. Revenue (US$ Mn) Comparison, By Distribution Channel 

10.7. Revenue (US$ Mn) Comparison, By Mode of Delivery 

11. Global Pharyngitis Market Company Share, Competition Landscape and Company Profiles

11.1. Company Share Analysis

11.2. Competition Landscape

11.3. Company Profiles

       11.3.1. GlaxoSmithKline PLC

       11.3.2. Pfizer Inc.

       11.3.3. Teva Pharmaceutical Industries Limited

       11.3.4. Merck KGaA

       11.3.5. Sanofi

       11.3.6. Abbott Laboratories Inc.

       11.3.7. Novartis AG

       11.3.8. Zambon Group SpA

       11.3.9. BioStar Pharmaceuticals, Inc.

12. Research Methodology

13. Secondary and Primary Sources

14. Assumptions and Acronyms

15. Disclaimer

Know More Details About the Report

List of Tables

TABLE 1 Global Pharyngitis Market Value (US$ Mn), 2012-2017

TABLE 2 Global Pharyngitis Market Value (US$ Mn), 2018-2026

TABLE 3 Global Pharyngitis Market Value (US$ Mn) and Y-o-Y, 2017-2026

TABLE 4 Global Beta Lactams Segment Value (US$ Mn), By Region 2012-2017

TABLE 5 Global Beta Lactams Segment Value (US$ Mn), By Region 2018-2026

TABLE 6 Global Beta Lactams Segment Market Share, By Region 2012-2017

TABLE 7 Global Beta Lactams Segment Market Share, By Region 2018-2026

TABLE 8 Global Beta Lactams Segment Y-o-Y, By Region 2017-2026

TABLE 9 Global Macrolides Segment Value (US$ Mn), By Region 2012-2017

TABLE 10 Global Macrolides Segment Value (US$ Mn), By Region 2018-2026

TABLE 11 Global Macrolides Segment Market Share, By Region 2012-2017

TABLE 12 Global Macrolides Segment Market Share, By Region 2018-2026

TABLE 13 Global Macrolides Segment Y-o-Y, By Region 2017-2026

TABLE 14 Global Cephalosporins Segment Value (US$ Mn), By Region 2012-2017

TABLE 15 Global Cephalosporins Segment Value (US$ Mn), By Region 2018-2026

TABLE 16 Global Cephalosporins Segment Market Share, By Region 2012-2017

TABLE 17 Global Cephalosporins Segment Market Share, By Region 2018-2026

TABLE 18 Global Cephalosporins Segment Y-o-Y, By Region 2017-2026

TABLE 19 Global Fluoroquinolones Segment Value (US$ Mn), By Region 2012-2017

TABLE 20 Global Fluoroquinolones Segment Value (US$ Mn), By Region 2018-2026

TABLE 21 Global Fluoroquinolones Segment Market Share, By Region 2012-2017

TABLE 22 Global Fluoroquinolones Segment Market Share, By Region 2018-2026

TABLE 23 Global Fluoroquinolones Segment Y-o-Y, By Region 2017-2026

TABLE 24 Global Tetracycline Segment Value (US$ Mn), By Region 2012-2017

TABLE 25 Global Tetracycline Segment Value (US$ Mn), By Region 2018-2026

TABLE 26 Global Tetracycline Segment Market Share, By Region 2012-2017

TABLE 27 Global Tetracycline Segment Market Share, By Region 2018-2026

TABLE 28 Global Tetracycline Segment Y-o-Y, By Region 2017-2026

TABLE 29 Global Other Products Segment Value (US$ Mn), By Region 2012-2017

TABLE 30 Global Other Products Segment Value (US$ Mn), By Region 2018-2026

TABLE 31 Global Other Products Segment Market Share, By Region 2012-2017

TABLE 32 Global Other Products Segment Market Share, By Region 2018-2026

TABLE 33 Global Other Products Segment Y-o-Y, By Region 2017-2026

TABLE 34 Global Hospital Pharmacies Segment Value (US$ Mn), By Region 2012-2017

TABLE 35 Global Hospital Pharmacies Segment Value (US$ Mn), By Region 2018-2026

TABLE 36 Global Hospital Pharmacies Segment Market Share, By Region 2012-2017

TABLE 37 Global Hospital Pharmacies Segment Market Share, By Region 2018-2026

TABLE 38 Global Hospital Pharmacies Segment Y-o-Y, By Region 2017-2026

TABLE 39 Global Retail Pharmacies and Drug Stores Segment Value (US$ Mn), By Region 2012-2017

TABLE 40 Global Retail Pharmacies and Drug Stores Segment Value (US$ Mn), By Region 2018-2026

TABLE 41 Global Retail Pharmacies and Drug Stores Segment Market Share, By Region 2012-2017

TABLE 42 Global Retail Pharmacies and Drug Stores Segment Market Share, By Region 2018-2026

TABLE 43 Global Retail Pharmacies and Drug Stores Segment Y-o-Y, By Region 2017-2026

TABLE 44 Global Online Pharmacies Segment Value (US$ Mn), By Region 2012-2017

TABLE 45 Global Online Pharmacies Segment Value (US$ Mn), By Region 2018-2026

TABLE 46 Global Online Pharmacies Segment Market Share, By Region 2012-2017

TABLE 47 Global Online Pharmacies Segment Market Share, By Region 2018-2026

TABLE 48 Global Online Pharmacies Segment Y-o-Y, By Region 2017-2026

TABLE 49 Global Oral Segment Value (US$ Mn), By Region 2012-2017

TABLE 50 Global Oral Segment Value (US$ Mn), By Region 2018-2026

TABLE 51 Global Oral Segment Market Share, By Region 2012-2017

TABLE 52 Global Oral Segment Market Share, By Region 2018-2026

TABLE 53 Global Oral Segment Y-o-Y, By Region 2017-2026

TABLE 54 Global Intravenous Segment Value (US$ Mn), By Region 2012-2017

TABLE 55 Global Intravenous Segment Value (US$ Mn), By Region 2018-2026

TABLE 56 Global Intravenous Segment Market Share, By Region 2012-2017

TABLE 57 Global Intravenous Segment Market Share, By Region 2018-2026

TABLE 58 Global Intravenous Segment Y-o-Y, By Region 2017-2026

TABLE 59 Global Intramuscular Segment Value (US$ Mn), By Region 2012-2017

TABLE 60 Global Intramuscular Segment Value (US$ Mn), By Region 2018-2026

TABLE 61 Global Intramuscular Segment Market Share, By Region 2012-2017

TABLE 62 Global Intramuscular Segment Market Share, By Region 2018-2026

TABLE 63 Global Intramuscular Segment Y-o-Y, By Region 2017-2026

TABLE 64 Global Other Mode of Delivery Segment Value (US$ Mn), By Region 2012-2017

TABLE 65 Global Other Mode of Delivery Segment Value (US$ Mn), By Region 2018-2026

TABLE 66 Global Other Mode of Delivery Segment Market Share, By Region 2012-2017

TABLE 67 Global Other Mode of Delivery Segment Market Share, By Region 2018-2026

TABLE 68 Global Other Mode of Delivery Segment Y-o-Y, By Region 2017-2026

TABLE 69 North America Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016

TABLE 70 North America Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016

TABLE 71 North America Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016

TABLE 72 North America Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016

TABLE 73 North America Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016

TABLE 74 North America Pharyngitis Market Value (US$ Mn), By Country 2012-2017

TABLE 75 North America Pharyngitis Market Value (US$ Mn), By Country 2018-2026

TABLE 76 North America Pharyngitis Market Value (US$ Mn), By Drug Class 2012-2017

TABLE 77 North America Pharyngitis Market Value (US$ Mn), By Drug Class 2018-2026

TABLE 78 North America Pharyngitis Market Value (US$ Mn), By Distribution Channel 2012-2017

TABLE 79 North America Pharyngitis Market Value (US$ Mn), By Distribution Channel 2018-2026

TABLE 80 North America Pharyngitis Market Value (US$ Mn), By Mode of Delivery 2012-2017

TABLE 81 North America Pharyngitis Market Value (US$ Mn), By Mode of Delivery 2018-2026

TABLE 82 Latin America Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016

TABLE 83 Latin America Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016

TABLE 84 Latin America Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016

TABLE 85 Latin America Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016

TABLE 86 Latin America Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016

TABLE 87 Latin America Pharyngitis Market Value (US$ Mn), By Country 2012-2017

TABLE 88 Latin America Pharyngitis Market Value (US$ Mn), By Country 2018-2026

TABLE 89 Latin America Pharyngitis Market Value (US$ Mn), By Drug Class 2012-2017

TABLE 90 Latin America Pharyngitis Market Value (US$ Mn), By Drug Class 2018-2026

TABLE 91 Latin America Pharyngitis Market Value (US$ Mn), By Distribution Channel 2012-2017

TABLE 92 Latin America Pharyngitis Market Value (US$ Mn), By Distribution Channel 2018-2026

TABLE 93 Latin America Pharyngitis Market Value (US$ Mn), By Mode of Delivery 2012-2017

TABLE 94 Latin America Pharyngitis Market Value (US$ Mn), By Mode of Delivery 2018-2026

TABLE 95 Europe Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016

TABLE 96 Europe Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016

TABLE 97 Europe Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016

TABLE 98 Europe Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016

TABLE 99 Europe Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016

TABLE 100 Europe Pharyngitis Market Value (US$ Mn), By Country 2012-2017

TABLE 101 Europe Pharyngitis Market Value (US$ Mn), By Country 2018-2026

TABLE 102 Europe Pharyngitis Market Value (US$ Mn), By Drug Class 2012-2017

TABLE 103 Europe Pharyngitis Market Value (US$ Mn), By Drug Class 2018-2026

TABLE 104 Europe Pharyngitis Market Value (US$ Mn), By Distribution Channel 2012-2017

TABLE 105 Europe Pharyngitis Market Value (US$ Mn), By Distribution Channel 2018-2026

TABLE 106 Europe Pharyngitis Market Value (US$ Mn), By Mode of Delivery 2012-2017

TABLE 107 Europe Pharyngitis Market Value (US$ Mn), By Mode of Delivery 2018-2026

TABLE 108 Japan Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016

TABLE 109 Japan Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016

TABLE 110 Japan Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016

TABLE 111 Japan Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016

TABLE 112 Japan Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016

TABLE 113 Japan Pharyngitis Market Value (US$ Mn), By Country 2012-2017

TABLE 114 Japan Pharyngitis Market Value (US$ Mn), By Country 2018-2026

TABLE 115 Japan Pharyngitis Market Value (US$ Mn), By Drug Class 2012-2017

TABLE 116 Japan Pharyngitis Market Value (US$ Mn), By Drug Class 2018-2026

TABLE 117 Japan Pharyngitis Market Value (US$ Mn), By Distribution Channel 2012-2017

TABLE 118 Japan Pharyngitis Market Value (US$ Mn), By Distribution Channel 2018-2026

TABLE 119 Japan Pharyngitis Market Value (US$ Mn), By Mode of Delivery 2012-2017

TABLE 120 Japan Pharyngitis Market Value (US$ Mn), By Mode of Delivery 2018-2026

TABLE 121 APEJ Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016

TABLE 122 APEJ Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016

TABLE 123 APEJ Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016

TABLE 124 APEJ Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016

TABLE 125 APEJ Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016

TABLE 126 APEJ Pharyngitis Market Value (US$ Mn), By Country 2012-2017

TABLE 127 APEJ Pharyngitis Market Value (US$ Mn), By Country 2018-2026

TABLE 128 APEJ Pharyngitis Market Value (US$ Mn), By Drug Class 2012-2017

TABLE 129 APEJ Pharyngitis Market Value (US$ Mn), By Drug Class 2018-2026

TABLE 130 APEJ Pharyngitis Market Value (US$ Mn), By Distribution Channel 2012-2017

TABLE 131 APEJ Pharyngitis Market Value (US$ Mn), By Distribution Channel 2018-2026

TABLE 132 APEJ Pharyngitis Market Value (US$ Mn), By Mode of Delivery 2012-2017

TABLE 133 APEJ Pharyngitis Market Value (US$ Mn), By Mode of Delivery 2018-2026

TABLE 134 MEA Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016

TABLE 135 MEA Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016

TABLE 136 MEA Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016

TABLE 137 MEA Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016

TABLE 138 MEA Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016

TABLE 139 MEA Pharyngitis Market Value (US$ Mn), By Country 2012-2017

TABLE 140 MEA Pharyngitis Market Value (US$ Mn), By Country 2018-2026

TABLE 141 MEA Pharyngitis Market Value (US$ Mn), By Drug Class 2012-2017

TABLE 142 MEA Pharyngitis Market Value (US$ Mn), By Drug Class 2018-2026

TABLE 143 MEA Pharyngitis Market Value (US$ Mn), By Distribution Channel 2012-2017

TABLE 144 MEA Pharyngitis Market Value (US$ Mn), By Distribution Channel 2018-2026

TABLE 145 MEA Pharyngitis Market Value (US$ Mn), By Mode of Delivery 2012-2017

TABLE 146 MEA Pharyngitis Market Value (US$ Mn), By Mode of Delivery 2018-2026

Have a report related query? Speak to us directly

List of Figures

FIG. 1 Global Pharyngitis Market Value (US$ Mn), 2012-2017

FIG. 2 Global Pharyngitis Market Value (US$ Mn) Forecast, 2018-2026

FIG. 3 Global Pharyngitis Market Value (US$ Mn) and Y-o-Y, 2017-2026

FIG. 4 Global Beta Lactams Segment Market Value (US$ Mn) By Region, 2012-2017

FIG. 5 Global Beta Lactams Segment Market Value (US$ Mn) By Region, 2018-2026

FIG. 6 Global Beta Lactams Segment Y-o-Y Growth Rate, By Region, 2017-2026

FIG. 7 Global Macrolides Segment Market Value (US$ Mn) By Region, 2012-2017

FIG. 8 Global Macrolides Segment Market Value (US$ Mn) By Region, 2018-2026

FIG. 9 Global Macrolides Segment Y-o-Y Growth Rate, By Region, 2017-2026

FIG. 10 Global Cephalosporins Segment Market Value (US$ Mn) By Region, 2012-2017

FIG. 11 Global Cephalosporins Segment Market Value (US$ Mn) By Region, 2018-2026

FIG. 12 Global Cephalosporins Segment Y-o-Y Growth Rate, By Region, 2017-2026

FIG. 13 Global Fluoroquinolones Segment Market Value (US$ Mn) By Region, 2012-2017

FIG. 14 Global Fluoroquinolones Segment Market Value (US$ Mn) By Region, 2018-2026

FIG. 15 Global Fluoroquinolones Segment Y-o-Y Growth Rate, By Region, 2017-2026

FIG. 16 Global Tetracycline Segment Market Value (US$ Mn) By Region, 2012-2017

FIG. 17 Global Tetracycline Segment Market Value (US$ Mn) By Region, 2018-2026

FIG. 18 Global Tetracycline Segment Y-o-Y Growth Rate, By Region, 2017-2026

FIG. 19 Global Other Products Segment Market Value (US$ Mn) By Region, 2012-2017

FIG. 20 Global Other Products Segment Market Value (US$ Mn) By Region, 2018-2026

FIG. 21 Global Other Products Segment Y-o-Y Growth Rate, By Region, 2017-2026

FIG. 22 Global Hospital Pharmacies Segment Market Value (US$ Mn) By Region, 2012-2017

FIG. 23 Global Hospital Pharmacies Segment Market Value (US$ Mn) By Region, 2018-2026

FIG. 24 Global Hospital Pharmacies Segment Y-o-Y Growth Rate, By Region, 2017-2026

FIG. 25 Global Retail Pharmacies and Drug Stores Segment Market Value (US$ Mn) By Region, 2012-2017

FIG. 26 Global Retail Pharmacies and Drug Stores Segment Market Value (US$ Mn) By Region, 2018-2026

FIG. 27 Global Retail Pharmacies and Drug Stores Segment Y-o-Y Growth Rate, By Region, 2017-2026

FIG. 28 Global Online Pharmacies Segment Market Value (US$ Mn) By Region, 2012-2017

FIG. 29 Global Online Pharmacies Segment Market Value (US$ Mn) By Region, 2018-2026

FIG. 30 Global Online Pharmacies Segment Y-o-Y Growth Rate, By Region, 2017-2026

FIG. 31 Global Oral Segment Market Value (US$ Mn) By Region, 2012-2017

FIG. 32 Global Oral Segment Market Value (US$ Mn) By Region, 2018-2026

FIG. 33 Global Oral Segment Y-o-Y Growth Rate, By Region, 2017-2026

FIG. 34 Global Intravenous Segment Market Value (US$ Mn) By Region, 2012-2017

FIG. 35 Global Intravenous Segment Market Value (US$ Mn) By Region, 2018-2026

FIG. 36 Global Intravenous Segment Y-o-Y Growth Rate, By Region, 2017-2026

FIG. 37 Global Intramuscular Segment Market Value (US$ Mn) By Region, 2012-2017

FIG. 38 Global Intramuscular Segment Market Value (US$ Mn) By Region, 2018-2026

FIG. 39 Global Intramuscular Segment Y-o-Y Growth Rate, By Region, 2017-2026

FIG. 40 Global Other Mode of Delivery Segment Market Value (US$ Mn) By Region, 2012-2017

FIG. 41 Global Other Mode of Delivery Segment Market Value (US$ Mn) By Region, 2018-2026

FIG. 42 Global Other Mode of Delivery Segment Y-o-Y Growth Rate, By Region, 2017-2026

FIG. 43 North America Pharyngitis Market Value (US$ Mn), By Country 2012-2017

FIG. 44 North America Pharyngitis Market Value (US$ Mn), By Country 2018-2026

FIG. 45 North America Pharyngitis Market Value (US$ Mn), By Drug Class 2012-2017

FIG. 46 North America Pharyngitis Market Value (US$ Mn), By Drug Class 2018-2026

FIG. 47 North America Pharyngitis Market Value (US$ Mn), By Distribution Channel 2012-2017

FIG. 48 North America Pharyngitis Market Value (US$ Mn), By Distribution Channel 2018-2026

FIG. 49 North America Pharyngitis Market Value (US$ Mn), By Mode of Delivery 2012-2017

FIG. 50 North America Pharyngitis Market Value (US$ Mn), By Mode of Delivery 2018-2026

FIG. 51 Latin America Pharyngitis Market Value (US$ Mn), By Country 2012-2017

FIG. 52 Latin America Pharyngitis Market Value (US$ Mn), By Country 2018-2026

FIG. 53 Latin America Pharyngitis Market Value (US$ Mn), By Drug Class 2012-2017

FIG. 54 Latin America Pharyngitis Market Value (US$ Mn), By Drug Class 2018-2026

FIG. 55 Latin America Pharyngitis Market Value (US$ Mn), By Distribution Channel 2012-2017

FIG. 56 Latin America Pharyngitis Market Value (US$ Mn), By Distribution Channel 2018-2026

FIG. 57 Latin America Pharyngitis Market Value (US$ Mn), By Mode of Delivery 2012-2017

FIG. 58 Latin America Pharyngitis Market Value (US$ Mn), By Mode of Delivery 2018-2026

FIG. 59 Europe Pharyngitis Market Value (US$ Mn), By Country 2012-2017

FIG. 60 Europe Pharyngitis Market Value (US$ Mn), By Country 2018-2026

FIG. 61 Europe Pharyngitis Market Value (US$ Mn), By Drug Class 2012-2017

FIG. 62 Europe Pharyngitis Market Value (US$ Mn), By Drug Class 2018-2026

FIG. 63 Europe Pharyngitis Market Value (US$ Mn), By Distribution Channel 2012-2017

FIG. 64 Europe Pharyngitis Market Value (US$ Mn), By Distribution Channel 2018-2026

FIG. 65 Europe Pharyngitis Market Value (US$ Mn), By Mode of Delivery 2012-2017

FIG. 66 Europe Pharyngitis Market Value (US$ Mn), By Mode of Delivery 2018-2026

FIG. 67 Japan Pharyngitis Market Value (US$ Mn), By Country 2012-2017

FIG. 68 Japan Pharyngitis Market Value (US$ Mn), By Country 2018-2026

FIG. 69 Japan Pharyngitis Market Value (US$ Mn), By Drug Class 2012-2017

FIG. 70 Japan Pharyngitis Market Value (US$ Mn), By Drug Class 2018-2026

FIG. 71 Japan Pharyngitis Market Value (US$ Mn), By Mode of Delivery 2012-2017

FIG. 72 Japan Pharyngitis Market Value (US$ Mn), By Distribution Channel 2018-2026

FIG. 73 Japan Pharyngitis Market Value (US$ Mn), By Mode of Delivery 2012-2017

FIG. 74 Japan Pharyngitis Market Value (US$ Mn), By Mode of Delivery 2018-2026

FIG. 75 APEJ Pharyngitis Market Value (US$ Mn), By Country 2012-2017

FIG. 76 APEJ Pharyngitis Market Value (US$ Mn), By Country 2018-2026

FIG. 77 APEJ Pharyngitis Market Value (US$ Mn), By Drug Class 2012-2017

FIG. 78 APEJ Pharyngitis Market Value (US$ Mn), By Drug Class 2018-2026

FIG. 79 APEJ Pharyngitis Market Value (US$ Mn), By Distribution Channel 2012-2017

FIG. 80 APEJ Pharyngitis Market Value (US$ Mn), By Distribution Channel 2018-2026

FIG. 81 APEJ Pharyngitis Market Value (US$ Mn), By Mode of Delivery 2012-2017

FIG. 82 APEJ Pharyngitis Market Value (US$ Mn), By Mode of Delivery 2018-2026

FIG. 83 MEA Pharyngitis Market Value (US$ Mn), By Country 2012-2017

FIG. 84 MEA Pharyngitis Market Value (US$ Mn), By Country 2018-2026

FIG. 85 MEA Pharyngitis Market Value (US$ Mn), By Drug Class 2012-2017

FIG. 86 MEA Pharyngitis Market Value (US$ Mn), By Drug Class 2018-2026

FIG. 87 MEA Pharyngitis Market Value (US$ Mn), By Distribution Channel 2012-2017

FIG. 88 MEA Pharyngitis Market Value (US$ Mn), By Distribution Channel 2018-2026

FIG. 89 MEA Pharyngitis Market Value (US$ Mn), By Mode of Delivery 2012-2017

FIG. 90 MEA Pharyngitis Market Value (US$ Mn), By Mode of Delivery 2018-2026

A sore throat or pharyngitis is caused when a virus infects the area of the throat. Some of the most common causes of pharyngitis is viral infections such as the influenza and common cold. Acute pharyngitis is one of the most common condition, hence, there has been an increase in demand for systematic treatment and medication. Drug manufacturers are also focusing on research and development of new drugs to treat pharyngitis without causing any side-effects. This Fact.MR report analyzes the expansion of global pharyngitis market till date, and provides key insights on the growth of the market during the forecast period, 2017-2026.

Scope

The scope of Fact.MR’s report is to analyze the global pharyngitis market for the forecast period 2017-2026 and provide readers an unbiased and accurate analysis. Medical device manufacturers, research institutes, and raw material suppliers in the global pharyngitis market can benefit from the analysis offered in this report. This report offers a comprehensive analysis, which can be of interest to leading trade magazines and medical journals pertaining to pharyngitis.

Summary

The report commences with a brief information of the global pharyngitis market. This executive summary sets the tone for the rest of the report, providing users the scope of the report. The executive summary includes important facts and statistics on the global pharyngitis market.

Overview

The next section offers an overview of the global pharyngitis market. This comprises an introduction to the market, along with a standard definition of the product – pharyngitis. In this section, market value and year-over-year growth is offered to the readers. Year-over-year growth provides readers with a broader view of growth patterns over the forecast period.

The report’s succeeding section focuses on drivers, restraints and key trends from macroeconomic, demand, and supply perspectives. Impact analysis of weighted average model-based growth drivers is contained in the report for better provision of decision-making insights to clients.

In order to offer readers with up-to-date information about the latest advancements in the global pharyngitis market, the report provides updates about market opportunities, which can benefit leading manufacturers of pharyngitis. With continuous evolution of the healthcare sector, keeping a record of latest developments and trends is fundamental for pharyngitis manufacturers to formulate key business strategies. Detailed insights about raw material sourcing, supply chain, regulatory approvals, pricing analysis, list of distributors, and cost structure are provided in this section.

Considering the broad scope of the global pharyngitis market, the report by Fact.MR provides in-depth and segment-wise analysis and forecast. The global pharyngitis market is segmented on the basis of drug class, distribution channel, mode of delivery, and region. This segmentation also includes country-wise analysis by taking into account all the major parameters of the global pharyngitis market.

The report’s last section comprises of the global pharyngitis market competitive landscape, to provide readers with the dashboard view of company analysis and market players. This competitive intelligence is based on the providers’ categories across value chain, and their presence in the global pharyngitis market.

Research Methodology

Fact.MR is committed to offer unbiased and independent market research solutions to its clients. Each market report of Fact.MR is compiled after months of exhaustive research. We bank on a mix of tried-and-tested and innovative research methodologies to offer the most comprehensive and accurate information. Our main sources of research include,

  • Primary research
  • Secondary research
  • Trade research
  • Focused interviews
  • Social media analysis

Need an Exclusive Report for your Unique Requirement?

- Related Reports -

Veterinary Catheters Market

Growing demand for veterinary catheters is driven by the rising prevalence & recurrence of chronic r...

Heart Failure Monitoring Systems Market

Heart Failure Monitoring Systems Market research report covers detailed information on Global Heart ...

Diverticular Disease Therapeutics Market

Diverticular Disease Therapeutics Market research report covers detailed information on Global Diver...

Dermatology Devices Market

Dermatology Devices Market expects a 12.5% CAGR by 2031. Rising specialized treatments & surgeries b...

- Our Clients -

Report Client

- Evaluate How Fact.MR's Report Can Help. -

Is the market research conducted by Fact.MR?

Yes, the report has been compiled by expert analysts of Fact.MR, through a combination of primary and secondary research. To know more about how the research was conducted, you can speak to a research analyst.

What research methodology is followed by Fact.MR?

Fact.MR follows a methodology that encompasses the demand-side assessment of the market, and triangulates the same through a supply-side analysis. This methodology is based on the use of standard market structure, methods, and definitions.

What are the sources of secondary research?

Fact.MR conducts extensive secondary research through proprietary databases, paid databases, and information available in the public domain. We refer to industry associations, company press releases, annual reports, investor presentations, and research papers. More information about desk research is available upon request.

Who are the respondents for primary research?

Fact.MR speaks to stakeholders across the spectrum, including C-level executives, distributors, product manufacturers, and industry experts. For a full list of primary respondents, please reach out to us.

Is a sample of this report available for evaluation?

Yes, you can request a sample, and it will be sent to you through an email.